9th ACE Drug Discovery Summit 

05th – 06th May 2027

Marriott International, San Diego, USA

About Us

The 9th Ace Drug Discovery Summit USA 2027 is a premier scientific forum uniting global researchers, biotech leaders, and pharma innovators to explore the latest advancements transforming drug discovery. This two-day summit features cutting-edge sessions on AI-driven drug design, quantum computing in simulation, targeted protein degradation, RNA therapeutics, and sustainable medicinal chemistry. Key discussions will highlight CAR-T cell therapies, immunotherapy combinations, bioinformatics, and nanomedicine, reflecting the evolving landscape of pharmaceutical R&D. Attendees will gain actionable insights into emerging technologies, fragment-based drug design, and AI-powered screening, with a strong focus on unmet medical needs and ethical considerations. With interactive panel discussions, expert-led presentations, and exclusive business meetings, the summit fosters meaningful collaboration and knowledge exchange across the drug development spectrum. Join us to stay at the forefront of innovation and reshape the future of drug discovery and therapeutic development.

Why Attend

Attendees
0 +
Speakers
0 +
Companies
0 +
Networking Hours
0 +

Solutions at ADDS

🔷Antibody Engineering
🔷Biochemistry
🔷Bio-informatics
🔷ADME/PK
🔷Biomarker Validation
🔷Combinatorial Chemistry
🔷Translational Research
🔷Data Management
     Technology

🔷Digital Imaging Technology
🔷DNA & RNA Analysis
🔷DNA Sequencing Services
🔷Drug Discovery Technology
     Platforms
🔷Preclinical
🔷Computational Biology
🔷Regulatory Affairs

🔷Research & Development
🔷Transgenesis Services
🔷Genomics
🔷High Throughput Screening
🔷Licensing
🔷lmaging/biomarker
🔷Data & AI

Who Will Attend

The 9th Ace Drug Discovery Summit USA 2027 is a premier scientific forum uniting global researchers, biotech leaders, and pharma innovators to explore the latest advancements transforming drug discovery.

🔷CEO
🔷CSO
🔷Director Discovery Alliances
🔷Head of DMPK
🔷Head of Drug Design

🔷Head of Molecula Toxicology
🔷VP Target Discovery & Assessment
🔷Head of R&D Licensing
🔷Principal Scientist

🔷Director of Discovery Strategy Portfolio
🔷Director of Screening & Compound Profiling
🔷Executive Director Chemistry
🔷Head Pharmacology & Toxicology
🔷Drug Discovery R&D Executives

ADVISORY BOARD MEMBERS

HAJNALKA HARTL

Head of Chemistry

OROGEN THERAPEUTICS

PHILIP M ARLEN

CEO

PRECISION BIOLOGICS

XIN ZHANG

Sr. Director, Computational Chemistry

CELLARITY

CHESTER YUAN

CSO

SUNGENING BIOSCIENCES

Rameshwar Kadam

Senior Scientist II

Johnson and Johnson Innovative Medicine

Shicheng Guo

Senior Director

Arrowhead Pharmaceuticals

Speaker Panel

Szymon Komorowski

Pharma & Life Sciences Advisor |
Deepsense

Riccardo Canevari

CEO | Radiopharm Theranostics

Nicholas Wisniewski

Director of Computational Biology | Valo Health

Aridaman Pandit

Head of Target ID, Systems Immunology and Immune Profiling | Abbvie

Hariprasad Vankayalapati

Chief Scientific Officer |
Biolexis Therapeutics

Vinicius Martins de Oliveira

Senior Scientist |
Novo Nordisk

Gary Altman

CEO | Cambium Oncology

Elena Molokanova

CEO |
NeurANO Bioscience

Virgil Woods

Senior Scientist |
Model Medicines

Anindya Bagchi

Co-Founder |
Styx Biotechnologies Inc

Shicheng Guo

Senior Director |
Arrowhead Pharmaceuticals

Julia Coronella

Former Vice President of Immuno-oncology |
Poseida Therapeutics, Inc.

Bo Chen

Associate Director, Drug Discovery |
Arrowhead Pharmaceuticals

Tony Yaksh

Professor |
UC San Diego

Vivek Gupta

Associate Professor |
St. John’s University

Jitendra Kumar

Lead Scientist: Chemistry and Process Development |
Entos Pharmaceuticals US, Inc.

Kinkini Roy

Principal, Director of Research |
Stealth Mode Biotech

Amy He

Research Scientist |
Topos Bio

Rose Yu

Associate Professor |
UC San Diego

Shane Lewin

CEO |
Clockwork Bio

Milad Rouhimoghadam

Senior Scientist |
AbbVie

MaryLena Bleile

Statistician | Independent

Sara Dochnal

Postdoctoral Fellow |
UC San Diego

Ruben Abagyan

Professor |
University of California, San Diego

David Gonzalez

Professor |
UC San Diego

Attendee Breakdown

Attendee Demographics

Conference Themes

05th May

Next-Generation Drug Discovery and Molecular Design
Biomarker Discovery for Precision Oncology
Next Generation Target Discovery through AI
Translational Research in the Era of Precision Medicine
Targeting Neurological Diseases through Gene Therapy Approaches
The Evolution of in vitro models
Transforming RNA Target Identification with Bioinformatics

06th May

Computational Medicinal Chemistry for Lead Optimization
Novel approaches for cell & gene therapy
Sustainable Practices in Medicinal Chemistry
In-silico Drug Design
Advancing ADC Development Through AI-Based PBPK Modeling
How successful are AI/ML Approaches in Drug Development
Next Generation Target Discovery through AI

Our Sponsors

10x_GENOMICS_LOGO

Our Partners

Media Partners

Marriott International begins as an A&W Root Beer franchise in Washington, D.C., in May 1927, with the same core values that guide the company today. Founders J. Willard and Alice Sheets Marriott get their business started by quenching people’s thirst during the hot, muggy summers in Washington, D.C., before serving food and becoming The Hot Shoppes, and entering other lines of business. Heralding in a new era in 2016, Marriott International acquires Starwood Hotels & Resorts Worldwide creating the world’s largest hotel company. There is a celebration in New York City’s Time Square.

Join industry leaders at the 9th ACE Drug Discovery Summit .